Notice: This company has been marked as potentially delisted and may not be actively trading. Anzu Special Acquisition Corp I (ANZU) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends ANZU vs. RBOT, MLSS, APT, SPAI, NTRB, CLGN, COCH, LFWD, POAI, and HSCSShould you be buying Anzu Special Acquisition Corp I stock or one of its competitors? The main competitors of Anzu Special Acquisition Corp I include Vicarious Surgical (RBOT), Milestone Scientific (MLSS), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), ReWalk Robotics (LFWD), Predictive Oncology (POAI), and Heart Test Laboratories (HSCS). These companies are all part of the "surgical appliances & supplies" industry. Anzu Special Acquisition Corp I vs. Vicarious Surgical Milestone Scientific Alpha Pro Tech Safe Pro Group Inc. Common Stock Nutriband CollPlant Biotechnologies Envoy Medical ReWalk Robotics Predictive Oncology Heart Test Laboratories Vicarious Surgical (NYSE:RBOT) and Anzu Special Acquisition Corp I (NASDAQ:ANZU) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations. Which has more risk & volatility, RBOT or ANZU? Vicarious Surgical has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, Anzu Special Acquisition Corp I has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500. Is RBOT or ANZU more profitable? Anzu Special Acquisition Corp I's return on equity of -17.33% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Vicarious SurgicalN/A -81.46% -63.62% Anzu Special Acquisition Corp I N/A -17.33%1.37% Do insiders and institutionals have more ownership in RBOT or ANZU? 47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 27.3% of Anzu Special Acquisition Corp I shares are held by institutional investors. 11.7% of Vicarious Surgical shares are held by company insiders. Comparatively, 0.7% of Anzu Special Acquisition Corp I shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer RBOT or ANZU? Vicarious Surgical received 8 more outperform votes than Anzu Special Acquisition Corp I when rated by MarketBeat users. CompanyUnderperformOutperformVicarious SurgicalOutperform Votes833.33% Underperform Votes1666.67% Anzu Special Acquisition Corp IN/AN/A Which has higher valuation & earnings, RBOT or ANZU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVicarious SurgicalN/AN/A-$71.07M-$10.29-1.17Anzu Special Acquisition Corp IN/AN/A$19.23MN/AN/A Does the media favor RBOT or ANZU? In the previous week, Vicarious Surgical's average media sentiment score of 1.94 beat Anzu Special Acquisition Corp I's score of 0.44 indicating that Vicarious Surgical is being referred to more favorably in the media. Company Overall Sentiment Vicarious Surgical Very Positive Anzu Special Acquisition Corp I Neutral Do analysts rate RBOT or ANZU? Vicarious Surgical presently has a consensus price target of $10.25, indicating a potential downside of 14.58%. Given Vicarious Surgical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Vicarious Surgical is more favorable than Anzu Special Acquisition Corp I.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Anzu Special Acquisition Corp I 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryVicarious Surgical beats Anzu Special Acquisition Corp I on 7 of the 10 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Anzu Special Acquisition Corp I News Delivered to You Automatically Sign up to receive the latest news and ratings for ANZU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANZU vs. The Competition Export to ExcelMetricAnzu Special Acquisition Corp ISurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.65M$9.52B$5.14B$9.08BDividend YieldN/A1.39%5.09%4.23%P/E RatioN/A19.5690.0517.18Price / SalesN/A32.801,116.25117.05Price / Cash3.7422.3743.1037.85Price / Book-0.985.494.784.78Net Income$19.23M$182.72M$120.31M$225.60M Anzu Special Acquisition Corp I Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANZUAnzu Special Acquisition Corp IN/A$1.65-10.3%N/A-26.7%$24.65MN/A0.003Gap UpRBOTVicarious Surgical1.2841 of 5 stars$13.40-5.9%$10.25-23.5%+3.5%$79.17MN/A-1.383Positive NewsMLSSMilestone Scientific2.1552 of 5 stars$0.82-2.8%$1.25+52.4%+57.4%$63.87M$8.88M-12.0630Analyst ForecastNews CoverageAPTAlpha Pro TechN/A$5.18-1.1%N/A+1.7%$56.98M$59.29M14.16120SPAISafe Pro Group Inc. Common StockN/A$3.94-5.5%N/AN/A$54.21M$1.56M0.0011News CoveragePositive NewsNTRBNutriband0.408 of 5 stars$4.35-2.2%N/A+60.0%$48.33M$2.09M-6.2710Positive NewsGap UpCLGNCollPlant Biotechnologies2.1292 of 5 stars$3.62-1.9%$12.50+245.3%-35.0%$41.47M$650,000.00-2.3770Positive NewsCOCHEnvoy Medical3.2104 of 5 stars$1.78+0.9%$8.00+350.7%-26.7%$35.94M$278,000.000.0034News CoverageGap UpLFWDReWalk Robotics3.3637 of 5 stars$1.66+1.8%$13.00+683.1%N/A$14.62M$25.00M-0.6560Positive NewsGap UpHigh Trading VolumePOAIPredictive Oncology2.2462 of 5 stars$0.71-5.3%$3.00+322.3%-76.7%$4.74M$1.48M-0.2530News CoverageGap UpHSCSHeart Test Laboratories2.2783 of 5 stars$3.68-4.4%$15.00+307.6%-75.7%$3.36M$18,600.00-0.1610Earnings ReportAnalyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies RBOT Competitors MLSS Competitors APT Competitors SPAI Competitors NTRB Competitors CLGN Competitors COCH Competitors LFWD Competitors POAI Competitors HSCS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ANZU) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anzu Special Acquisition Corp I Please log in to your account or sign up in order to add this asset to your watchlist. Share Anzu Special Acquisition Corp I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
